Rival European pharma giants Sanofi and GSK have both forged new partnerships to bolster their preclinical research. | Rival ...
With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | On ...
Pharmaceutical Technology on MSN
GSK obtains FDA approval for Exdensur in severe asthma
Exdensur is now the first twice-yearly add-on maintenance therapy approved for use in severe eosinophilic asthma.
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. PARIS (AP) — Sanofi and GlaxoSmithKline’s ...
First and only next-generation protein-based adjuvanted COVID-19 booster approved in Europe Strong immune response against all tested variants of concern Ready to supply for fall-winter COVID-19 ...
The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback